The Pioneer in UV Disinfection to Exhibit at APIC
Tru-D SmartUVC invites attendees to learn more about UV market's only total room disinfection robot
CHARLOTTE, N.C., June 6, 2016 - Tru-D SmartUVC, the pioneer in the UV disinfection space, will attend APIC, June 11-13 in Charlotte, North Carolina. APIC delivers the largest annual conference of infection preventionists from across the U.S., and Tru-D invites the more than 2,500 attendees to stop by their booth #1026.
"Tru-D is the only device of its kind that provides and guarantees total room disinfection," said Chuck Dunn, president and CEO of Tru-D SmartUVC. "We are excited to bring more awareness to the fight against HAIs and demonstrate how Tru-D is the gold standard in terminal room disinfection."
Deployed in hundreds of hospitals throughout the country, Tru-D is a germ-eliminating robot used in patients' and operating rooms after an environmental service member has completed traditional cleaning methods. Using its patented Sensor360 technology, Tru-D analyzes the dynamic makeup of each room including size, shape and contents, to deliver a lethal dose of UVC light, killing up to 99.9% of pathogens in the room. Administering a single, measured cycle of UVC light from a single position, Tru-D removes the guesswork along with any chance of human error in the cleaning process.
"Tru-D's Sensor360 technology allows for complete disinfection of an entire space each and every time," said Dunn. "Rather than estimating the UV dose needed or focusing only on high-touch areas, Tru-D provides total room disinfection, giving patients and staff peace of mind."
The most studied device of its kind and validated by more than a dozen, independent, third-party studies, Tru-D was the only UV disinfection device selected for the first-ever, randomized, clinical trial on UV disinfection. The Benefits of Enhanced Terminal Room Disinfection (BETR-D) study funded by the Centers for Disease Control and Prevention proved that enhanced cleaning technologies reduced the cumulative incidence of multidrug-resistant organisms such as C. diff, MRSA and VRE by up to 30 percent, and the greatest decreases were seen when Tru-D was added to the standard cleaning practices.
For more information and links to independent studies, visit Tru-D.com.
About Tru-D SmartUVC
Tru-D SmartUVC is the only UV disinfection device backed by a CDC-funded, randomized clinical trial to show that it is capable of reducing the transmission of health care-associated infections by up to 30 percent. More Tru-Ds have been deployed to disinfect hospitals across the globe than all other competing look-alike offerings, fighting deadly pathogens such as C. diff, MRSA, CRE, VRE, MERS, Ebola and many more. An effective and innovative technology backed by sound science, Tru-D SmartUVC is on a mission to eradicate HAIs making hospitals safer places for patients and staff. For information and links to independent studies on Tru-D, visit Tru-D.com.
MEDIA CONTACT:
Christin Yates
Tru-D Public Relations
901-774-5771
SOURCE Tru-D SmartUVC
Web Site: tru-d.com
